ResMed
313 hedge funds and large institutions have $4.21B invested in ResMed in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 114 increasing their positions, 110 reducing their positions, and 51 closing their positions.
4% more repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 110
0.67% more ownership
Funds ownership: 52.33% → 53% (+0.67%)
4% less funds holding
Funds holding: 326 → 313 (-13)
20% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 51
20% less capital invested
Capital invested by funds: $5.27B → $4.21B (-$1.06B)
39% less call options, than puts
Call options by funds: $20.1M | Put options by funds: $32.9M
56% less funds holding in top 10
Funds holding in top 10: 9 → 4 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$115M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
+$54.4M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$51.8M |
| 4 |
T
TOBAM
Paris,
France
|
+$42.9M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$26.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$124M |
| 2 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$74M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$35.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$31.1M |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
-$13M |
RMD Hedge Fund Activity: Q2 2015 in Review
313 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q2 2015, worth a combined $4.21B — down 20% from $5.27B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of RMD and 41 opened new positions — a net loss of 10 holders — while 110 trimmed existing stakes and 114 added.
The largest buyer was Capital Research Global Investors, adding an estimated $115M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $124M sold.
- 313 institutional investors held ResMed (RMD) as of Q2 2015, down from 326 in Q1 2015.
- Funds reported $4.21B of ResMed stock for Q2 2015, down 20% quarter-over-quarter.
- 41 funds opened new ResMed positions in Q2 2015 and 51 closed out, a net change of -10 holders.
- The largest ResMed buyer in Q2 2015 was Capital Research Global Investors, an estimated $115M added.
- The largest ResMed seller in Q2 2015 was OppenheimerFunds, an estimated $124M sold.
Based on aggregated 13F filings for Q2 2015.